FDA Inspection 1077704 — Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. on December 7, 2018 in Jinhua. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 7, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinhua (China)